AAAAAA

   
Results: 1-9 |
Results: 9
Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
Authors: Clarke, NRA Kelion, AD Nixon, J Hilton-Jones, D Forfar, JC
Citation: Nra. Clarke et al., Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?, HEART, 86(4), 2001, pp. 411-416
Inflammatory muscle diseases
Authors: Hilton-Jones, D
Citation: D. Hilton-jones, Inflammatory muscle diseases, CURR OP NEU, 14(5), 2001, pp. 591-596
Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenneand Becker muscular dystrophies and controls
Authors: Grain, L Cortina-Borja, M Forfar, C Hilton-Jones, D Hopkin, J Burch, M
Citation: L. Grain et al., Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenneand Becker muscular dystrophies and controls, NEUROMUSC D, 11(2), 2001, pp. 186-191
Myasthenia gravis
Authors: Vincent, A Palace, J Hilton-Jones, D
Citation: A. Vincent et al., Myasthenia gravis, LANCET, 357(9274), 2001, pp. 2122-2128
A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999
Authors: Al-Shahi, R Warlow, CP Jansen, GH Frijns, CJM van Gijn, J Fuller, G Garfield, J Hilton-Jones, D Harrison, M McDonald, I Donaghy, M Bates, D Lammie, A
Citation: R. Al-shahi et al., A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999, J NE NE PSY, 71(5), 2001, pp. 696-703
Oculopharyngeal muscular dystrophy - Phenotypic and genotypic studies in aUK population
Authors: Hill, ME Creed, GA McMullan, TFW Tyers, AG Hilton-Jones, D Robinson, DO Hammans, SR
Citation: Me. Hill et al., Oculopharyngeal muscular dystrophy - Phenotypic and genotypic studies in aUK population, BRAIN, 124, 2001, pp. 522-526
Magnetic resonance spectroscopy evidence of abnormal cardiac energetics inXp21 muscular dystrophy
Authors: Crilley, JG Boehm, EA Rajagopalan, B Blamire, AM Styles, P Muntoni, F Hilton-Jones, D Clarke, K
Citation: Jg. Crilley et al., Magnetic resonance spectroscopy evidence of abnormal cardiac energetics inXp21 muscular dystrophy, J AM COL C, 36(6), 2000, pp. 1953-1958
New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1)
Authors: Gonzalez, I Ohsawa, N Singer, RH Devillers, M Ashizawa, T Balasubramanyam, A Cooper, TA Khajavi, M Lia-Baldini, AS Miller, G Philips, AV Timchenko, LT Waring, J Yamagata, H Barbet, JP Klesert, TR Tapscott, SJ Roses, AD Wagner, M Baiget, M Martorell, L Browne, GB Eymard, B Gourdon, G Junien, C Seznec, H Carey, N Gosling, M Maire, P Gennarelli, M Sato, S Ansved, T Kvist, U Eriksson, M Furling, D Chen, EJ Housman, DE Luciano, B Siciliano, M Spring, N Shimizu, M Eddy, E Morris, GE Krahe, R Furuya, H Adelman, J Pribnow, D Furutama, D Mathieu, J Hilton-Jones, D Kinoshita, M Abbruzzese, C Sinden, RR Wells, RD Pearson, CE Kobayashi, T Johansson, A Salvatori, S Perryman, B Swanson, MS Gould, FK Harris, SE Johnson, K Mitchell, AM Monckton, DG Winchester, CL Antonini, G Day, JW Liquori, C Ranum, LPW Westerlaken, J Wieringa, B Griffith, JD Michalowski, S Moore, H Hamshere, M Korade, Z Thornton, CA Jaeger, H Lehmann, F Moorman, JR Mounsey, JP Mahadevan, MS
Citation: I. Gonzalez et al., New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1), NEUROLOGY, 54(6), 2000, pp. 1218-1221
Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by P-31-magnetic resonance spectroscopy
Authors: Lodi, R Taylor, DJ Tabrizi, SJ Hilton-Jones, D Squier, MV Seller, A Styles, P Schapira, AHV
Citation: R. Lodi et al., Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by P-31-magnetic resonance spectroscopy, BRAIN, 121, 1998, pp. 2119-2126
Risultati: 1-9 |